Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Leukemia, Myeloid, Acute 19Myelodysplastic Syndromes 4Leukemia 3Congenital Abnormalities 3Mastocytosis, Systemic 2Recurrence 1Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Mastocytosis 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Mast-Cell 1Leukemia, Erythroblastic, Acute 1Leukemia, Eosinophilic, Acute 1Leukemia, Biphenotypic, Acute 1Leukemia, Basophilic, Acute 1Blast Crisis 1Aggression 1

Interventions

Imatinib Mesylate 2midostaurin 1fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Watchful Waiting 1Transplantation 1Tacrolimus 1Single-Cell Gene Expression Analysis 1Radiotherapy 1Phlebotomy 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Injections 1Hydroxychloroquine 1Dasatinib 1Cyclophosphamide 1Cladribine 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Mastocytosis × midostaurin × Clear all
NCT01920204 2015-01-19

Midostaurin in Indolent Systemic Mastocytosis

University Medical Center Groningen

Phase 2 Unknown
20 enrolled
Myeloid

Mastocytosis, Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡